Clustering of metabolic factors among the patients with essential hypertension

Bangladesh Medical Research Council Bulletin

Volumn 34, Issue 3, 2008, Pages 71-75

  Siddique, Md Abu ^a   Sultan, Md Ashraf Uddin ^a   Sirajul Haque, K M H S ^a   Zaman, Mohammad Mostafa ^b   Ahmed, Chaudhury Meshkat ^a   Rahim, Md Abdur ^a   Salman, Mohammad ^a  

^a BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

^b National Center for Control of Rheumatic Fever and Heart Diseases   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; WAIST CIRCUMFERENCE;

ADULT; AGED; BANGLADESH; BLOOD GLUCOSE; CHOLESTEROL, HDL; FEMALE; HUMANS; HYPERTENSION; LIFE STYLE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS; TOBACCO USE DISORDER; TRIGLYCERIDES; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 65649115509     PISSN: 03779238     EISSN: None     Source Type: Journal    
DOI: 10.3329/bmrcb.v34i3.1856     Document Type: Article

References (23)

1. Wilson PW, Grundy SM. The metabolic syndrome: Practical guide to origins and treatment: Part I. Circulation 2003; 108: 1422-24.
2. Wilson PW, Grundy SM. The metabolic syndrome: A practical guide to origins and treatment: Part II. Circulation 2003; 108: 1537-40.
3. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DJ, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108: 414-19.
4. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52: 1210-14.
5. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-28.
6. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen M, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-89.
7. National Heart Lung and Blood Institute. Executive summary of the third report of the National Cholesterol Education Program (NCEP): Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
8. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; 337: 382-86.
9. Samuelsson O, Wilhelmsen L, Elmfoldt D. Predictors of cardiovascular morbidity in treated hypertension: Results from the primary preventive trial in Göteborg, Sweden. J Hypertens. 1985; 3: 167-76.
10. Zavaroni I, Mazza S, Dall'Aglio E, Gasparini P, Passeri M, Reaven GM. Prevalence of hyperinsulinemia in patients with high blood pressure. J Intern Med. 1992; 231: 235-40.
11. Guidelines Committee. 2003 European Society of Hypertension, European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003; 21: 1011-53.
12. Reaven GM: Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988: 37: 1595-607.
13. Zaman MM, Choudhury SR, Ahmad J, Noman SM, Islam SM, Parvin K. Prevalence of metabolic syndrome in a rural population of Bangladesh. Diabetes Care 2006; 29: 1456-57.
14. Park HS, Oh SW, Cho S, Choi WH, Kim YS. The metabolic syndrome and associated life style factors among South Korean adults. Int J Epidemiol. 2004; 33: 328-36.
15. Greenlund KJ, Valdej R, Casper ML, Rith-Najarian S, Croft JB. Prevalence and correlates of the insulin resistance syndrome among native Americans. Diabetes Care 1999; 22: 441-47.
16. McKiegue PM, Pierpoint T, Ferric JE, Maromot MG. Relationship of glucose intolerance and hyperinsulinemia to body fat pattern in South Asians and Europeans. Diabetologia 1992; 35: 785-91.
17. Kong C, Nimmo L, Elatrozy T. Smoking associated with increased hepatic lipase activity, insulin resistance, dyslipidemia and early atherosclerosis in type 2 diabetes. Atherosclerosis 2001; 156: 373-78.
18. Tahtinen TM, Vanhala MJ, Oikarinen JA, Keinanen-Kiukaanniemi SM. Effect of smoking on the prevalence of insulin resistance-associated cardiovascular risk factors among Finnish men in military service. J Cardiovasc Risk 1998; 5: 319-23.
19. Shimokata H, Muller DC, Anders R. Studies in the distribution of body fat. III. Effects of cigarette smoking. JAMA 1989; 261: 1169-73.
20. Bleich S, Bleich K. Moderate alcohol consumption and the risk of cardiovascular disease. Ain J Clin Nutr. 2002; 75: 948.
21. Lamon-Fava S. High-density lipoproteins: Effects of alcohol, estrogen, and phytoestrogens. Nutr Rev. 2002; 60: 1-7.
22. Gillman MW, Cook NR, Evans DA, Rosner B, Hennekens CH. Relationship of alcohol intake with blood pressure in young adults. Hypertension 1995; 25: 1106-10.
23. Zaman MM, Choudhury SR, Ahmed J, Yosiike N, Noman SM, Islam MS, Parvin K. Plasma lipids in rural population of Bangladesh. Eur J Cardiovasc Prev Rehabil. 2006; 13: 444-48.